CN1067531C - Health-care chitosan-chitin food - Google Patents
Health-care chitosan-chitin food Download PDFInfo
- Publication number
- CN1067531C CN1067531C CN97100243A CN97100243A CN1067531C CN 1067531 C CN1067531 C CN 1067531C CN 97100243 A CN97100243 A CN 97100243A CN 97100243 A CN97100243 A CN 97100243A CN 1067531 C CN1067531 C CN 1067531C
- Authority
- CN
- China
- Prior art keywords
- chitosan
- chitin
- powder
- food
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920002101 Chitin Polymers 0.000 title claims abstract description 99
- 235000013305 food Nutrition 0.000 title claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 235000000832 Ayote Nutrition 0.000 claims abstract description 8
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 8
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 8
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 8
- 240000001980 Cucurbita pepo Species 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 31
- 230000006196 deacetylation Effects 0.000 claims description 15
- 238000003381 deacetylation reaction Methods 0.000 claims description 15
- 239000008234 soft water Substances 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 238000005406 washing Methods 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 11
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 8
- 230000007935 neutral effect Effects 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 235000012204 lemonade/lime carbonate Nutrition 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 210000001161 mammalian embryo Anatomy 0.000 claims description 6
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 239000001506 calcium phosphate Substances 0.000 claims description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 4
- 235000011010 calcium phosphates Nutrition 0.000 claims description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 4
- 238000002479 acid--base titration Methods 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 241000219051 Fagopyrum Species 0.000 claims 3
- 238000007873 sieving Methods 0.000 claims 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract description 5
- 235000005473 carotenes Nutrition 0.000 abstract description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 abstract description 5
- 150000001746 carotenes Chemical class 0.000 abstract description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 244000130270 Fagopyrum tataricum Species 0.000 abstract 1
- 235000014693 Fagopyrum tataricum Nutrition 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229920001661 Chitosan Polymers 0.000 description 49
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 40
- 210000004027 cell Anatomy 0.000 description 31
- 230000006870 function Effects 0.000 description 26
- 210000004698 lymphocyte Anatomy 0.000 description 21
- 235000012000 cholesterol Nutrition 0.000 description 17
- 230000009466 transformation Effects 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 239000002516 radical scavenger Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 230000000242 pagocytic effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000000835 fiber Substances 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- 230000001681 protective effect Effects 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 210000000941 bile Anatomy 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 240000008620 Fagopyrum esculentum Species 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 235000001727 glucose Nutrition 0.000 description 5
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 210000002540 macrophage Anatomy 0.000 description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000035911 sexual health Effects 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 240000004244 Cucurbita moschata Species 0.000 description 3
- 241001269238 Data Species 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 241000623906 Lytta vesicatoria Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 229940109850 royal jelly Drugs 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 229960001005 tuberculin Drugs 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- POFMQEVZKZVAPQ-UHFFFAOYSA-N 1,1,1',1'-tetramethyl-3,3'-spirobi[2h-indene]-5,5',6,6'-tetrol Chemical compound C12=CC(O)=C(O)C=C2C(C)(C)CC11C2=CC(O)=C(O)C=C2C(C)(C)C1 POFMQEVZKZVAPQ-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 206010004173 Basophilia Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- HNNQYHFROJDYHQ-UHFFFAOYSA-N 3-(4-ethylcyclohexyl)propanoic acid 3-(3-ethylcyclopentyl)propanoic acid Chemical compound CCC1CCC(CCC(O)=O)C1.CCC1CCC(CCC(O)=O)CC1 HNNQYHFROJDYHQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000007058 Halophila ovalis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000792844 Xylotrupes Species 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002156 adsorbate Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 125000001912 carotene group Chemical group 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000000222 eosinocyte Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 239000000568 immunological adjuvant Substances 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- QTENRWWVYAAPBI-YCRXJPFRSA-N streptomycin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QTENRWWVYAAPBI-YCRXJPFRSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a health-care food, particularly to an application of chitosan-chitin on a functional health-care food, and a health-care chitosan-chitin food is provided. The health-care chitosan-chitin food comprises chitosan-chitin powder produced by a method of the present invention and comprises a composition of the chitosan-chitin powder and pumpkin powder tartarian buckwheat crystal and also comprises a composition of chitosan-chitin powder, lecithin, phyteral powder and carotene.
Description
The present invention relates to protective foods, specifically be meant the application of chitosan-chitin on function Sexual health promotion food, health-care chitosan-chitin food promptly is provided.
Protective foods is of a great variety on the market at present, and summarize and get up to mainly contain five big classes: the first kind is general heath food, as green alga, royal jelly, genseng, soya-bean milk, healthy tea, honey, wheat tooth oil, rolled oats etc.Second class is a nature food, as coarse food grain, organic vegetable, sea grass class, fruits, mineral substance.The 3rd class is the hypoglycemic based food, as salt-poor diet, food with low sugar content, low-cholesterol food, newly lose weight the sweet taste material, incubate phosphatide.The 4th class is a nourishing reinforced food, as vitamin-E, Ca and multivitamin, micro-nutrient fortified food.The 5th class is a new type health food, as sports beverages, bacillus bifidus beverage, lactobacillus drink.Above product major part is used for replenishing the shortage of human body to certain nutrition, has only the minority protective foods to belong to functional foodstuff, as ginseng royal jelly and bacillus bifidus breast bacteria beverage etc.Royal jelly has the function that delays senility, but contain certain female hormone, and it is edible to be not suitable for children, and active substance needs preserve in-18 ℃ refrigerator, otherwise volatility.With bacillus bifidus, milk-acid bacteria is the beverages such as SANZHU KOUFUYE of raw material, and the adjusting function of human body is arranged, and improves the function of inside of human body environment, but the main active substances bacillus bifidus, its active being difficult to keeps, and owing to above reason, makes its effect be subjected to very big influence.Therefore being badly in need of the new function Sexual health food resource of exploitation, for this series products, requiring the physicochemical character of its active substance to stablize, do not contain or contain hormone substance less as far as possible, do not have extreme chemical reaction, is pure natural, multi-functional protective foods.Chitosan-chitin can be described as a kind of ideal protective foods resource, the condition that its characteristic conforms is above-mentioned.
The object of the invention is to provide the application of chitosan-chitin on function Sexual health promotion food, and health-care chitosan-chitin food promptly is provided.
Health-care chitosan-chitin food provided by the present invention can be the chitosan-chitin powder that adopts method of the present invention to produce.
Health-care chitosan-chitin food provided by the present invention also can be the chitosan-chitin powder that method of the present invention is produced and the composition of the bitter buckwheat crystalline substance of pumpkin powder, and specifically each composition proportion is (weight percent is represented):
Chitosan-chitin 30%
Pumpkin powder 10%
Bitter buckwheat crystalline substance 60%
The brilliant raw material of wherein bitter buckwheat is the Radix Et Rhizoma Fagopyri Tatarici of height above sea level more than 1800 meters, wears into powder, shells and embryo is separated, and again embryo is worn into powder.
Health-care chitosan-chitin food provided by the present invention can also be chitosan-chitin powder and Yelkin TTS that method of the present invention is produced, and plants the matter end, the composition of carotene, and specifically each composition proportion is (weight percent is represented):
Chitosan-chitin 90%
Yelkin TTS 5%
Plant matter end 3%
Carotene 2%
The production method of chitosan provided by the present invention-chitin powder comprises: select ordorlessly, the crab leg in the red deep-sea of do not have rotting cleans up, oven dry.At room temperature handled 22 hours with 4%HCl solution then, make inorganic salt such as contained lime carbonate and calcium phosphate be converted into calcium chloride and remove.After the filtration, until raffinate acid, it is neutral that the alkali detection paper is with the soft water washing.NaOH solution-treated with excessive 10% 4 hours, temperature is controlled at 93 ± 2 ℃, removes deproteinize, fat.Filtration to neutral, afterwards with an amount of absolute ethanol washing, is drying to obtain the elaboration chitin with the soft water washing., survey its deacetylation by acid base titration and see whether reach more than 80%, generally be controlled at 90% 143 ℃ ± 2 ℃ heating 15 hours with 50%NaOH, reaction terminating filters, and is washed till neutrality with soft water, can get chitosan-chitin after the drying.Pulverize (on the stainless steel mill) and sieve and make it 100% by 80 orders, viscosity controller is at 70 ± 5mpa.s, sterilization.
Chitin and chitosan are that chitosan is to belong to the polyose animal fibre, are a kind of rising natural macromolecule amyloses, use very extensively, have showed wide application prospect in fields such as doctor, farming, light industry, chemical industry, weaving, environmental protection.China has also obtained some achievements at present, and " Hai Fukang " artificial skin of developing as Qingdao Marine University has obtained 37 eureka world inventions gold medals, country's 91 annual invention third prizes.The Chinese Academy of Sciences and the cooperation of The 2nd Army Medical College of PLA successfully extract this material from silkworm chrysalis, develop medical sewing thread, wound hemostasis film etc." the chitin artificial skin " of China Textile Science Inst. obtains national inventing patent.But chitosan-chitin directly is processed into protective foods still belongs to blank.The experiment proved that this material has no side effect, good with the tissue intermiscibility, physico-chemical property is stable, pharmaceutical use is preferably arranged, have enhance immunity power, broad-spectrum is antibacterial, promotes organization healing, hemostatic analgesia suppresses the tumour cell diffusion, and plurality of health care functions such as delay senility.Therefore pass through animal and human's body repetition test among the present invention, determine the best physical and chemical index scope of chitosan-chitin, and develop serial health-care chitosan-chitin food on this basis as function Sexual health promotion food.
1, the main physical and chemical of chitin-chitosan is:
1. viscosity: pure chitosan is a kind of white or translucent sheet of canescence or pulverulent solids; nothing is smelt, nontoxicity; the chitin molecular weight is about 1,000,000-2,000,000 in the organism; the back chitin molecular weight of purifying is about 300,000-700,000; chitosan molecular weight by chitin after deacetylated is then lower, is about 20-50 ten thousand.The molecular weight size of chitin and chitosan is often represented with their viscosity numerical value just.
2. degree of deacetylation: have strong hydrogen bond action between stable ring texture and the macromole owing to have in the chitin macromole, make them have stable physics, chemical property.Not fusion (200 ℃ of decomposition) is water insoluble again, and in diluted acid, diluted alkaline and the common organic solvents, chitin can dissolve in strong acid (vitriol oil, hydrochloric acid, nitric acid, 85% phosphoric acid etc.), but the degraded that chain takes place simultaneously obviously reduces molecular weight.The chitosan macromole is owing to ethanoyl has removed in a large number-NH
2Exist, make its solubility property be better than chitin greatly.It can be dissolved in most diluted acid, in (as formic acid, acetate, naphthenic acid, phenylformic acid etc.) and make uniform chitosan solution.Also active big because of chitosan, thus its dilute acid soln at room temperature viscosity reduce gradually, complete hydrolysis becomes glucosamine at last.
On chitin and chitosan macromolecular structure, they have the structure similar to vegetable fibre, all have an acetamido or amino to make chitin-chitosan have the structure of similar human body osso-albumin tissue on their macromolecular each repeating units.Their this dual structure has been given their fabulous biological medicine characteristics.Make they and human body have fabulous Bc.Can be decomposed by the intravital N,O-Diacetylmuramidase of biology and absorb, say that therefore the degree of deacetylation (being amino content) in the chitosan chitin is the main foundation of its health-care effect of decision.
3. granularity: the chitosan-chitin after the purification is fibrous should the pulverizing and grinds to form certain tiny particle, experiment showed, the more little absorption of human body that helps more of granularity repeatedly through us.
2, chitosan-chitinous extraction process
A kind of polysaccharide that chitin (Chitine) is a kind of straight-chain polymer of like fibrous element, formed by the N-acetylglucosamine monomer polymerization of similar glucose.The N-acetylglucosamine, chitin, chitosan, Mierocrystalline cellulose, the molecular configuration of glucose is as follows.Chitin is poly-smart as can be known is the product of chitin lose ethanoyl after the deacetylation effect after from molecular structure; it goes the acetyl degree is 65%-99%; because it is deacetylated fully still to have no idea in the world so far, so the product after deacetylated is commonly referred to chitosan-chitin (Chitosan-Chitin) (because of there are two kinds of compositions simultaneously in product) with chitin.
Chitin is commonly called as chitin, chitin, be that crustacean (as crab, shrimp) shell, insect (as cockroach, xylotrupes dichotomus) epidermis, mollusk (as cuttlefish, shellfish) organ, mushroom are (as mushroom, lichens) important composition of cell walls, nearly 1,000 hundred million tons at occurring in nature
The abundant Mierocrystalline cellulose that is only second to the land of resource.Chitin extracts more convenient from shrimp, crab shell in general, mainly contain three kinds of compositions in their crust, inorganic salt such as lime carbonate and calcium phosphate account for 45%, crude protein and fat account for 27%, chitin accounts for about 20%, chitinous content in all kinds of crusts, in the shrimp shell, account for 15-30%, account for 15-20% in the crab shell, mainly form by producing chitin in shrimp, the crab shell by two portions technology, remove lime carbonate and remove protein with hot diluted alkaline with dilute hydrochloric acid, the chitin of making has just been made chitosan again after concentrated base takes off acetyl.Conventional at present extracting method is: add rare NaOH in the crab shell to remove deproteinize, grind, add sulfurous acid with deliming, filter washing, drying.But, this preparation method's product is technical grade product roughing preparation method, can not be edible as food grade products, because the product ash oontent height of preparing like this (general ash oontent all＞5%), and heavy metal content is also higher, problem according to above existence, a large amount of research work have been done among the present invention, slave unit is to preparation technology, all improve, test of many times is groped the colory chitin of preparation food grade, chitosan best equipment and technology finally, we prepare chitin, the chitosan raw material mainly is a deep-sea crab shell, and its technical process is as follows:
Select the crab shell, add soft water and wash, add HCl and carry out acid treatment, add soft water and wash, add the NaOH soda boiling, add KMnO
4And the oxalic acid decolouring, drying adds dense NaOH and boils to take off acetyl, adds soft water and washes, and drying obtains chitosan and chitin mixture.
Concrete grammar is: the crab shell is selected cleaned up, oven dry, with the HCl (the reagent utmost point) of excessive 2mol solution reaction 4-5 hour, filter, at room temperature handled 20-24 hour with the HCl solution of 2mol again, make contained lime carbonate be converted into calcium chloride, remove, filter, the soft water washing is to neutral, with the NaOH solution-treated of excessive 5-10% 3-4 hour, temperature 90-95 ℃, remove deproteinize, can remove for several times remaining inorganic salt and protein such as lime carbonate repeatedly, 0.5%, stirred dipping one hour in the potassium permanganate again, soft water is washed the back and stir decolouring in 30-40 minute in 60-70 ℃ in 1% oxalic acid, through fully washing, with an amount of absolute ethanol washing, drying just can make yellow elaboration chitin at last, the chitin that last method makes heats 10-18 hour twice in 140 ℃ with 50% NaOH, filter then, to neutral, can get the white solid chitosan after drying with the soft water washing.Chitosan with method for preparing is superior in quality, meets food grade fully, and through small white mouse toxicological experiment active substance stability test, hygiology detects and the nourishing function test, all meets the standard of the new protective foods of Ministry of Health's formulation.
On above basis, we add other pure natural substance in chitosan-chitin, as pumpkin powder, Yelkin TTS, Radix Et Rhizoma Fagopyri Tatarici etc., and preparation chitosan chitin protective foods.
3, chitosan-chitinous main physical and chemical index and the relation of regulating immunologic function:
Nineteen sixty Nowell finds phytohaemagglutinin (Phytohemagylutin, PHA) and lymphocyte mix, carry out vitro culture, can see after a few days that the vigorous phenomenon of division appears in significantly large-scale parent cell, again find that the synthetic of lymphocytic protein and nucleic acid also increased when following morphological change thereafter.The lymph of PHA stimulation that Here it is transforms phenomenon.After prove tuberculin again in succession, the reacting positive body is a lymphocyte adding tuberculin, also occurs transforming phenomenon during vitro culture.When in the organ transplantation research work, finding the lymphocyte mixed culture of donor and acceptor, the combination that transformation efficiency is low, then the internal organs survival time of Yi Zhiing is long.All can the lymphocyte transformation phenomenon appear external from tuberculin reaction and immunclogical response of transplantation, so think that the cellular immunity of LTR and body has substantial connection.Lymphocyte transformation test at present has been widely used in the mensuration of body cell immunologic function.This test is tested with this method:
(1) material:
1. heparin preservative-free heparin injection 50 μ g/ml blood, or 0.4% rough hepar siccatum immersion liquid 0.1ml/ml blood.
2. 199 nutritive mediums contain foetal calf serum 15%, penicillin 100 μ g/ml, Streptomycin sulphate 100 μ g/ml.
3. chitosan-chitin: 0.5% acetum.
A. viscosity is 200mpa.s, 180mpa.s, 160mpa.s, 140mpa.s, 120mpa.s, 100mpa.s, 80mpa.s, 60mpa.s, 40mpa.s, (0.5%) 20 ℃
B. degree of deacetylation is 60% 70% 80% 90%
C. granularity is 60 orders, 70 orders, 80 orders, 90 orders
4. Hanks liquid
2, method
1. it is heavy even that white corpuscle culture method, extracting vein blood 1ml are put into calparine pipe, puts in 37 ℃ of incubators and leave standstill half an hour, treat that red corpuscle sinks, the partly about 0.5ml of leukocytic blood plasma is rich on the sucking-off upper strata, puts into the culturing bottle that the 3ml199 nutritive medium is housed, and adds corresponding chitosan-chitin solution again.Shake up back jam-pack soft rubber ball, put 37 ℃ of incubators, cultivated 72 hours.
2. smear staining method: cultivate when finishing, cell hang, move in the test tube, centrifugal 1000rpm 10min is sink to the pipe end with cell, and supernatant liquor is to the greatest extent treated that the residual small amount of liquid of tube wall is back to manage at the end, makes push jack with sharp suction pipe absorption cell.Dry back methyl alcohol is fixed, and dyes with auspiciousization staining.
3. sentence read result method: the size of the outstanding cell of the morphological criteria of interpretation parent cell, the ratio of nuclear and cell space, the dyeability of born of the same parents' dress, having or not of the structure of nuclear and kernel is divided into following four kinds of cells.
A. sophisticated small lymphocyte: the same 6-8 μ of lymphocyte when not cultivating, the karyomit(e) densification of nuclear, nuclear is big with the ratio of cell space, and endochylema dyeing is slight basophilia.
B. the lymphocyte of: bigger than small lymphocyte, about 8-12 μ, caryoplasm are fine and close too, and kernel occurs, and the endochylema dyeability is the same with above-mentioned cell.
C. lymphoblast: cell individual increases, about 12-20 μ, and form is irregular, and pimple is often arranged, and it is big that nuclear becomes, and kernel obviously appears in chromatin mercapto pine, and endochylema broadens, and nuclear diminishes with the cell space ratio, and endochylema is obviously basophilia by force, the endochylema cavity often occurs.
D. other cell: neutrophil leucocyte is after cultivating 72 hours, and overwhelming majority decay or death are fragment, however eosinophilic granulocyte after cultivating 72 hours, the overwhelming majority decays into death and is fragment.
Above-mentioned a, b item are no transformed cells, and the c item is a transformant, differentiate in the classification that main points are: the having or not of the structure of nuclear, particularly kernel.
4. the calculating of lymphocyte transformation rate: 200 lymphocytes of counting under high power or oily mirror
(3) result:
1. viscosity is to the influence (seeing Table 1) of lymphocyte transformation rate
Table 1 chitosan-chitinous viscosity is to the influence of lymphocyte transformation rate
| Viscosity mpa.s | 200 | 180 | 160 | 140 | 120 | 100 | 80 | 60 | 40 | CK |
| Transformation efficiency % | 13.4 | 19.5 | 30.2 | 47.8 | 48.1 | 51.3 | 71.9 | 80.5 | 80 | 11.5 |
Annotate: 1. data are three revision test average datas in the table
2. chitosan-chitinous deacetylation is 91% in the table, and granularity is 80 orders.
(2) degree of deacetylation sees Table 2 to the influence of mouse spleen lymphocyte transformation efficiency
Table 2 chitosan-chitin deacetylation is to the influence of lymphocyte transformation rate
| Degree of deacetylation % | 60 | 70 | 80 | 90 | CK |
| Transformation efficiency % | 34.9 | 41.2 | 68.9 | 74.3 | 10.5 |
Annotate: 1. data are three repetition average datas in the table
2. the chitinous viscosity of chitosan is 80 orders for the 75mpa.s granularity in the table
(3) granularity is to lymphocyte transformation rate influence (seeing Table 3)
Table 3 granularity influences lymphocyte transformation rate
| Granularity (order) | 60 | 70 | 80 | 100 | CK |
| Transformation efficiency % | 51.4 | 53.7 | 72.1 | 79.7 | 11.4 |
Annotate: 1. data are three revision test average datas in the table
2. chitosan-chitinous deacetylation is 91% in the table, and viscosity is 75mpa.s
More than in three tables CK be blank, promptly add chitosan-chitin.
Show from above data
(1) chitosan-chitinous viscosity transformation efficiency less than 100mpa.s the time obviously improves, this be explanation to be tried the thing molecular weight more little, its effect of regulating immunity function is good more.
(2) chitosan-chitinous deacetylation is 80% when above, and lymphocyte transformation rate is significantly improved, and illustrates that free amine group plays an important role regulating on the immunity function.
(3) chitosan-chitinous granularity is when 80 orders are above, and lymphocyte transformation rate improves, and illustrates that granularity is more little, is convenient to animal body and absorbs, and its immunomodulatory effect is good more.
4, the relation between chitosan-chitin and the macrophage phagocytic function
The intravital small lymphocyte of scavenger cell and machine all is to participate in immunoreactive main cell composition, and scavenger cell is being handled antigen and at important anti-infective of specific antibody and the collaborative performance down of lymphocyte, antitumor action.Some immunostimulant in addition, the function of the stimulation scavenger cell that immunological adjuvant is special, observation is in the particularly variation of malignant tumor patient of various diseases, objective indicator to therapeutic response, in human trial, be difficult for obtaining the scavenger cell for test of capacity, adopt the foaming of Chinese medicine Chinese blister beetle alcohol leach liquor can obtain result preferably at present, suitcase liquid and convenient sources, the chicken hemocyte that is easy to observe are at incubated in vitro, get cell and make smear, microscopy calculates to be engulfed percentage ratio and compares with normal value with phagocytic index, can estimate the phagocytic function of patient's scavenger cell.
(1) material
1. 10% Chinese blister beetle leach liquor, 10g Chinese medicine Chinese blister beetle are dipped in 100ml 95% alcohol port grinding bottle jam-pack, and to put refrigerator standby.
2. chicken cell suspension, the wing vein is got blood, and heparin 50ug/ml anti-freezing is put into Alsere ' preservation liquid with 1/10 ratio and was preserved one month, gives a baby a bath on the third day after its birth inferiorly with physiological saline with preceding, and it is standby to be made into 5% concentration.
3. tried thing: chitosan-chitin (for this case is extracted, viscosity: 75mpa.s, deacetylation: 91%, granularity 80 orders).
4. the animal subject small white mouse is divided four groups
I group: make it suffer from skin cancer, the feed (T that feeds and add chitosan
+)
II group: make it suffer from skin cancer, the feed (T that feeds and add chitosan
-)
III group: normal mice, the feed (CK that feeds and add chitosan
+)
IV group: normal mice, the feed (CK that feeds and do not add chitosan
-)
(2) method:
Get the Intraabdominal scavenger cell of animal subject, add the mixing that vibrates gently, put into 37 ℃ of water-baths through 5% chicken red blood cell 0.02ml of washing.Incubation 30 minutes, shook once in per therebetween 10 minutes, centrifugal, getting the sediment smear fixes, also can in the incubation process, add the cover plate bar, two opening and closing also, put into above-mentioned chicken red blood cell and expanding foam solution mixed solution test tube, scavenger cell is swashed along slide, after incubation finishes, the tegillum slide is taken out fixing, with the dyeing of Ji's nurse Sa (Ji's nurse Sa dye liquor is done 1/10 dilution with PH6 or 9, phosphoric acid buffer), dying 4-5 minute is flushable mounting with smear or the cover plate that is attached with scavenger cell, engulf the result with high power or oily spectroscopy, with following two index expression activate the phagocytic capacity:
A. percentage phagocytosis: the scavenger cell number that promptly gulps down chicken red blood cell in each hundred scavenger cell.
B. the number difference of each macrophage phagocytic chicken red blood cell (from zero to tens) 100 scavenger cells are made the chicken red blood cell that gulps down summation divided by 100, promptly get the scavenger cell index, i.e. the mean number of each macrophage phagocytic chicken red blood cell.Think that according to treatment and prevention of tumour institute of Chinese Academy of Medical Sciences test-results above-mentioned binomial index often is parallel, so only can reflect its activate the phagocytic capacity with percentage phagocytosis.
(3) result's (seeing Table 4)
The relation of table 4 chitosan and macrophage phagocytic function
| Group | Sample number | Activate the phagocytic capacity (%) |
| T + | 30 | 56.5 |
| T - | 30 | 39.3 |
| CK + | 30 | 69.4 |
| CK - | 30 | 62.7 |
Annotate: T
+Suffer from the knurl mouse and feed chitosan
T
-Suffer from the knurl mouse and do not feed chitosan
CK
+Normal mice is fed chitosan
CK
-Normal mice is not fed chitosan
From interpretation of result, the huge cytophagy activity of biting of trouble cancer mouse is minimum to be 39.3%.Bring up to 56.3% but suffer from the cancer mouse activate the phagocytic capacity of having fed behind the chitosan, normal mice is fed and has also been improved than the normal mice of not feeding chitosan behind the chitosan.Illustrate that chitosan-chitin has the activated effect to the phagocytic activity of scavenger cell.Thereby infer that the chitosan chitin can be regulated immunity function, have the function that suppresses tumour simultaneously.Result of study can be inferred DAC-70 via T-cell system activated macrophage (M φ), and may be by the B-cell system by the CM-chitin.
Protective foods provided by the present invention has been determined the best-of-breed technology indication range of chitosan chitin as new functional food, and its health-care effect will be enhanced.Except the function of above-mentioned adjusting immunity function, also will improve people's functions of intestines and stomach reducing fat sterol, hypotensive, hypoglycemic, remove harmful toxins in the human body, as heavy metal, agricultural chemicals etc., certain effect will be arranged.Below we are analyzed integral part one by one
1, regulates immunologic function (top existing detailed description)
(1) material
1. tried thing: chitosan-chitin
2. animal subject: exempt from son and divide two groups
The I high cholesterol diet of feeding does not add chitosan in the feed
The II high cholesterol diet of feeding, chitosan (2%) in addition in the feed
(2) method
After feeding one month, content of cholesterol in the test blood.
(3) result and analysis
Group I serum cholesterol value is up to 629mg;
Group II serum cholesterol value is 287mg.
This result illustrates that chitosan-chitin has the function that suppresses cholesterol.We know that cholesterol is the essential substance that constitutes human body midbrain, nerve, sexual hormoue, cytolemma etc., being used to digest and assimilate fatty bile acide also is that cholesterol is transformed, but when cholesterol surpasses normal value, can hoard in vessel wall, blood circulation is worsened, cause coronary heart disease, arteriosclerotic diseases such as myocardial infarction.Chitosan-chitin is to the inhibiting mechanism of cholesterol, tentatively be inferred as and prevent that 1. cholesterol from absorbing in vivo, chitosan is easy to the bile acide combination and all excretes, owing to lack the effect that bile acid has just suppressed enzyme, so cholesterol can't be transformed into the cholesterol ester that is easily absorbed by intestinal tube, thereby reduced cholesterol; 2. the absorption of overslaugh fat, chitosan contains the positively charged ion of positively charged, accumulates in vivo around the electronegative oil droplet, form barrier and the overslaugh absorption, fat in the blood is present in cholesterol and the proteinic particle, so along with the minimizing of blood fat fat, cholesterol level also can reduce thereupon.3. impel cholesterol to transform, cholesterol is an important component in the Digestive system that generated of liver inner cholesterol, certain reserves are arranged in gall-bladder, bile acide digests in perfect aspect usually, after absorbing the task of fat, absorb again and get back in the gall-bladder by small intestine, because of chitosan easily and bile acide in conjunction with also all excreting, in order to keep that a certain amount of bile acide deposit is arranged in the gall-bladder, cholesterol level must descend in the bile acide blood thereby just must be in liver cholesterol be changed into.
2, hypotensive
Vasoconstriction conversion enzyme (ACE) causes hypertensive major cause, the present invention is to contain high sodium-chlor, high sodium salt and high chlorine feed are fed normal mouse, found that, only the feed mouse increased blood pressure of feed of high sodium-chlor adds chitosan (deacetylation 91%, granularity 80 orders of our preparation then at feed, viscosity 70mpa.s), because the NH that dissociates in the chitosan
2 +Effect, impel the Cl ionic to drain, because activity and the Cl ionic relationships of ACE are close.Make the active reduction of ACE so the Cl ionic reduces, suppressed the rising of blood pressure.
3, hypoglycemic
Have in the human body and make blood glucose value keep certain robot control system(RCS), this is that many hormones all can make blood glucose value rise because the participation of various hormones is arranged, but has only Regular Insulin that blood glucose value is descended.If therefore pancreatic secretion Regular Insulin ability drop, or the situation of soma worsens, in the time of can't making full use of Regular Insulin, blood glucose value all can raise gradually.As everyone knows, in the prevention and treatment for diabetes, foodstuff fibre is very effective.And chitosan-chitin is the polycation fiber, and hypoglycemic function is arranged equally, and experimentation on animals has confirmed this point.
Respectively with containing chitosan-chitinous feed, the feed of general vegetable fibre and the feed that does not contain any fiber, feed the mouse that has suffered from diabetes, the result eats the urine sugar value of the mouse that contains chitosan-chitin feed and blood glucose value is all low than other two groups on an empty stomach.Illustrate that chitosan-chitin that we prepare has the effect that suppresses rising to blood sugar.
4, improve gastrointestinal function, improve constipation
Foodstuff fibre has the promotion enterogastric peristalsis, improve the effect of Digestive tract, have the function of general foodstuff fibre equally, also find in the experiment as the chitosan-chitin of polycation fiber, youngster's fourth glycan also can promote the propagation of beneficial bacteria in the intestines, and this is that general foodstuff fibre is unexistent.Fact proved, after a lot of people have eaten the chitosan chitin of our preparation, gastrointestinal system improves greatly, the stool of long-term diarrhea is shaped, the defecation of constipation is unobstructed, the people who suffers from various chronic gastropathies has obtained improvement in various degree, generally feels better than the SANZHU KOUFUYE of selling on the market now.This mainly is that the active ingredient stability of chitosan is fine, and the activity of the main active substances-bacillus bifidus in the SANZHU KOUFUYE is difficult to keep.
5, absorption objectionable impurities such as heavy metal and discharge the body place
Along with the progress of science and technology, also bring a lot of public hazards, cause human a lot of diseases that take place, what wherein be widely known by the people most is the heavy metal public hazards.Experiment shows that chitosan-chitin is owing to its specific molecule structure, and adsorbable heavy metal adds mercuric chloride solution (flow velocity 0.5ml/min) in filling up the pipe of chitosan.Test via the SP-9 atomic absorption spectrum, find that beginning absorption speed is higher, after about 2 hours, reach an equilibrium value, chitosan-chitin can be considered to be poromerics, and when the heterogeneous body polymkeric substance was lower than T8, the thermal motion meeting of key section was restricted and forms the molecule irregular stacking, so form micropore small molecules or ion are passed through, adsorption process roughly was divided into for three steps.Be that adsorbate moves on the adsorbent, and then diffusion, finally reach absorption.Find that in addition take off more height of acetyl degree, then adsorptive power is stronger, this is the decision of metal ion-chelant process kinetics.The mankind of this function under living in the environmental pollution serious condition now is very important.
6, improvement is had a pain in the back
The traditional Chinese medical science is paid attention to tip round-robin physiology very much.So hemostasis is arranged, the notion of water poison.Hemostasis is exactly the not smooth morbid state of gas, blood, water, during hemostasis tip circulation bad, shell temperature reduces, and becomes the disease of being afraid of cold because pair cell, muscle oxygen, the nutrient supply deficiency is so can cause and have a pain in the back.Just can improve the symptom of having a pain in the back as long as can expand the volume of blood flow of arteriole.But chitosan is the degradation production vagus nerve stimulation in vivo, makes the arteriole expansion via the excitement of autonomic nerve maincenter, has a pain in the back thereby improve.
Embodiment 1
Select ordorlessly, the crab leg in the red deep-sea of do not have rotting cleans up, oven dry.At room temperature handled 22 hours with 4%HCl solution then, make inorganic salt such as contained lime carbonate and calcium phosphate be converted into calcium chloride and remove.After the filtration, until raffinate acid, it is neutral that the alkali detection paper is with the soft water washing.Na0H solution-treated with excessive 10% 4 hours, temperature is controlled at 93 ± 2 ℃, removes deproteinize, fat.Filtration to neutral, afterwards with an amount of absolute ethanol washing, is drying to obtain the elaboration chitin with the soft water washing.Whether, survey its deacetylation by acid base titration and reach more than 80% 143 ℃ ± 2 ℃ heating 15 hours with 50%NaOH, generally be controlled at 90%, reaction terminating filters, and is washed till neutrality with soft water, can get chitosan-chitin after the drying.Pulverize (on the stainless steel mill) and sieve and make it 100% by 80 orders, viscosity controller is at 70 ± 5mpa.s.Sterilization.
With these product to animal experiment and human experiment.All demonstrate great health care function.
Embodiment 2
With the chitosan-chitin powder of preparation among the embodiment 1, mix the bitter growing the grain of pumpkin powder, specifically each composition proportion is (weight percent is represented):
Chitosan-chitin 30%
Pumpkin powder 10%
Bitter buckwheat crystalline substance 60%
* the brilliant raw material of bitter buckwheat is the Radix Et Rhizoma Fagopyri Tatarici of height above sea level more than 1800 meters, wears into powder, shells and embryo is separated, and again embryo is worn into powder.
The functional food major function of making of more than filling a prescription is hypoglycemic, and reducing blood-fat is the special-purpose functional food of diabetics.
Embodiment 3
With the chitosan-chitin powder of preparation among the embodiment 1, additional Yelkin TTS is planted the matter end, carotene.Concrete each composition proportion is (weight percent is represented):
Chitosan-chitin 90%
Yelkin TTS 5%
Plant matter end 3%
Carotene 2%
The functional food of this formulated will have better curative effect to cardiovascular and cerebrovascular patients such as hypertension, hyperlipidemia, hypercholesterolemia, arteriosclerosis, thrombus.
Give nearly 50 people's test-meals with made chitosan-chitin, generally reflection is good, lifts several examples below:
1. certain woman: 35 years old, it was swollen to suffer from the ovary bundle, edible chitosan-chitin powder, and every day, 6g after two months, constipation occurred.Continue to eat, week back constipation disappears, and has reduced about 1cm to the examination in hospital Ovarian Tumor.
2. certain woman is 47 years old, suffers from chronic gastritis for a long time, and eat chitosan chitin powder 2g every day, and after two months, stomach is flatulence no longer, pain, and appetite increases.
3. certain man is 57 years old, suffers from hypertension, hyperlipidemia, takes chitosan-chitin, every day 6g, after three months, blood pressure is basicly stable, and cholesterol is reduced to 195mg% by 238mg%, beta lipoprotein is reduced to 728mg% by 928mg%, and triglyceride is reduced to 269mg% by 445mg%.
4. certain man is 71 years old, suffers from late gastric cancer, hand formula not, and the doctor says maximum work 3 months.Edible chitosan-chitin, 6g-10g/ day every day, in high spirits after two months, appetite increases, and competent slight housework has repeatedly during this, but patient does not feel pain, survives half a year.
5. in addition, there are 5 examination trenchermans to find on one's body, face, the thrust of the mole of under-arm and monkey and so on, hardening is before this dwindled, and comes off then.
6. certain man, 51 years old, suffer from diabetes, edible chitosan chitin 6g every day, after two months, fasting plasma glucose drops to 104mg% by 146.2mg%, and urine becomes (-) by+1, glucose in urine by+4 become+2, after four months, spirit is clearly better, and continuous three months fasting plasma glucoses are at 74-86mg%, glucose in urine (-).
Claims (2)
1. health-care chitosan-chitin food, it is characterized in that adopting following method to produce chitosan-chitin powder: to select in the deep-sea ordorless, do not have and rot, red crab leg cleans up, oven dry, at room temperature handled 22 hours with 4%HCl solution then, making contained lime carbonate and calcium phosphate inorganic salt be converted into calcium chloride removes, filtering the back uses sour with the soft water washing until raffinate, it is neutral that the alkali detection paper is, NaOH solution-treated with excessive 10% 4 hours, temperature is controlled at 93 ± 2 ℃, remove deproteinize, fat, filtration is extremely neutral with the soft water washing, afterwards with an amount of absolute ethanol washing, be drying to obtain the elaboration chitin, heated 15 hours at 143 ℃ ± 2 ℃ with 50%NaOH, survey its deacetylation by acid base titration and see whether reach more than 80%, generally be controlled at 90%, reaction terminating filters, be washed till neutrality with soft water, can get chitosan-chitin after the drying, pulverizing on stainless steel mill and sieving makes it 100% by 80 orders, viscosity controller is at 70 ± 5mpa.s, after sterilization promptly obtains required chitosan-chitin powder.
2. the described health-care chitosan-chitin food of claim 1, it is characterized in that forming by chitosan-chitin powder and pumpkin powder, bitter buckwheat crystalline substance, each composition weight percentage: chitosan-chitin 30%, pumpkin powder 10%, bitter buckwheat crystalline substance 60%, the brilliant raw material of described bitter buckwheat is the Radix Et Rhizoma Fagopyri Tatarici of height above sea level more than 1800 meters, wears into powder, shell and embryo is separated, again embryo is worn into powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97100243A CN1067531C (en) | 1997-01-13 | 1997-01-13 | Health-care chitosan-chitin food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97100243A CN1067531C (en) | 1997-01-13 | 1997-01-13 | Health-care chitosan-chitin food |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1187948A CN1187948A (en) | 1998-07-22 |
| CN1067531C true CN1067531C (en) | 2001-06-27 |
Family
ID=5164903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97100243A Expired - Fee Related CN1067531C (en) | 1997-01-13 | 1997-01-13 | Health-care chitosan-chitin food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1067531C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1247819A1 (en) * | 2001-04-04 | 2002-10-09 | Dainichiseika Color & Chemicals Mfg. Co. Ltd. | Purified chitins and production process thereof |
| CN100491406C (en) * | 2006-11-24 | 2009-05-27 | 暨南大学 | A kind of synthetic method of phosphorylcholine chitosan derivative |
| CN104256246A (en) * | 2014-07-25 | 2015-01-07 | 湖北亿龙源食品有限公司 | Donkey-hide gelatin brown sugar and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1821471C (en) * | 1990-12-06 | 1993-06-15 | Дальневосточный технический институт рыбной промышленности и хозяйства | Process for preparing chitosan |
| JPH05279401A (en) * | 1992-03-31 | 1993-10-26 | Nippon Kayaku Co Ltd | Production of powdery chitosan |
| JPH06181725A (en) * | 1992-12-17 | 1994-07-05 | Kiteii:Kk | Agent for solidifying easily oxidizable oily substance |
| JPH07135923A (en) * | 1993-11-19 | 1995-05-30 | Takeo Tanabe | Composition for functional food |
-
1997
- 1997-01-13 CN CN97100243A patent/CN1067531C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1821471C (en) * | 1990-12-06 | 1993-06-15 | Дальневосточный технический институт рыбной промышленности и хозяйства | Process for preparing chitosan |
| JPH05279401A (en) * | 1992-03-31 | 1993-10-26 | Nippon Kayaku Co Ltd | Production of powdery chitosan |
| JPH06181725A (en) * | 1992-12-17 | 1994-07-05 | Kiteii:Kk | Agent for solidifying easily oxidizable oily substance |
| JPH07135923A (en) * | 1993-11-19 | 1995-05-30 | Takeo Tanabe | Composition for functional food |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1187948A (en) | 1998-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108753874A (en) | A kind of preparation method of small active peptides novel spirulina powder | |
| CN1457808A (en) | Iron scale dendrobium compound preposition and preparation and use | |
| CN102727872A (en) | Anti-aging and heart and blood vessel protecting soft capsule and preparation method thereof | |
| CN102505034B (en) | Method for preparing active polypeptide from corn protein powder | |
| CN1290862C (en) | Spleen polypeptide extract, its preparing process and use | |
| CN101028282A (en) | Use of low-molecular weight phaeophytin polyose sulfate in preparation of medicine for treating kidney disease | |
| CN1194703C (en) | Health-care food for protecting gastric mucosa and its preparing process | |
| CN1602758A (en) | Nutritious liquor (drink) for relieving the effect of alcohol, alcohol relieving capsule production method | |
| CN1204238C (en) | Kenrel oil composite extracted from plant kernel and its extraction process and application | |
| CN1067531C (en) | Health-care chitosan-chitin food | |
| CN102379391A (en) | Preparation of health food of pine pollen, glucan and natto | |
| CN101427778A (en) | Health care instant noodles and method of producing the same | |
| CN101053392A (en) | Soluble dietary fiber of konjak | |
| CN111280453B (en) | A kind of preparation method of Antrodia camphorata water-insoluble dietary fiber | |
| KR100548060B1 (en) | Manufacturing method of high functional mycelium using herbal resources and its mycelium | |
| CN1207308C (en) | Ganoderma applanatum polysaccharide, its preparation and medicine composition using said compound as active component | |
| CN1663608A (en) | Medicine for treating infantile anorexia | |
| CN1634555A (en) | Medicine for treating chronic gastritis | |
| CN1295247C (en) | Ganoderma lucidum polysaccharide protein and its preparing method and use | |
| CN1498626A (en) | Application of hyaluronic acid in raising immunity of human body and improving symptom of lacking immunity | |
| CN1883500A (en) | Application of low molecular weight citrus pectin in increasing immunity | |
| CN1733704A (en) | Synthesis and biological and pharmacological action of betaine salicylate | |
| CN1165551C (en) | Viva pertusa polyose for regulating blood fat and its preparing method | |
| CN1289100C (en) | Medicinal capsule with functions of postponing senility and regulating immune system and preparation method thereof | |
| CN112244244B (en) | A method for preparing thallus Porphyrae algae tablet with health promotion effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |